Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. SPY
5. ACN
6. IBM
7. PFE
8. TSLA
9. DPZ
10. NVDA

Go back to Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones
(NASDAQ: GCTK) Delayed: 0.36 --0 (-0%)
Previous Close $0.36    52 Week High $ 
Open $0.36    52 Week Low $ 
Day High $0.37    P/E N/A 
Day Low $0.35    EPS $ 
Volume 149,641       

(NASDAQ: GCTK) Delayed: 0.36 --0 (-0%)
Previous Close $0.36    52 Week High $ 
Open $0.36    52 Week Low $ 
Day High $0.37    P/E N/A 
Day Low $0.35    EPS $ 
Volume 149,641